Interdisciplinary Evaluation and Management of Asymptomatic Carotid Artery Stenosis: Pharmacological Optimization, Nursing Care Coordination, and Radiological Diagnostic Integration

Background: Asymptomatic carotid artery stenosis (ACAS), a narrowing of the carotid artery without recent neurological symptoms, is a common manifestation of systemic atherosclerosis and a marker for increased stroke and cardiovascular risk. Its management balances the prevention of future stroke against the risks of intervention. Aim: This review provides an interdisciplinary update on the evaluation and management of ACAS, integrating perspectives from radiological diagnostics, pharmacological optimization, and nursing care coordination to guide evidence-based, patient-centered decision-making. Methods: The synthesis is based on a comprehensive analysis of current guidelines, clinical trials, and cohort studies. It evaluates the roles of various diagnostic imaging modalities (duplex ultrasound, CTA, MRA) for risk stratification and examines the efficacy of best medical therapy (BMT) versus revascularization (CEA, CAS, TCAR). Results: Contemporary BMT, including statins, antiplatelets, and aggressive risk factor control, has significantly reduced the annual ipsilateral stroke risk to approximately 0.9-1%. This diminished baseline risk narrows the net benefit of routine revascularization. Current management therefore prioritizes BMT for most patients, reserving intervention for those with high-risk features such as stenosis progression, plaque vulnerability (e.g., intraplaque hemorrhage), or impaired cerebrovascular reserve. Conclusion: The management of ACAS has evolved towards a personalized, medical-first approach. Interdisciplinary collaboration is essential to identify high-risk patients who may benefit from revascularization while ensuring the majority receive optimized BMT. This strategy, supported by rigorous nursing coordination and advanced radiological diagnostics, optimizes outcomes by minimizing stroke risk and procedural harm.

Authors

Institutions

Publication Details

Journal
Saudi Journal of Medicine and Public Health
Published
2025-10-14
DOI
https://doi.org/10.64483/jmph-131
Primary Topic
Cerebrovascular and Carotid Artery Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Interdisciplinary Evaluation and Management of Asymptomatic Carotid Artery Stenosis: Pharmacological Optimization, Nursing Care Coordination, and Radiological Diagnostic Integration

Nawal Ahmed Abdu Hamdi, Yousef Alharbi, Ali Alharbi, Ahmed Alshehri et al.
Saudi Journal of Medicine and Public Health
Cerebrovascular and Carotid Artery Diseases
article

Interdisciplinary Evaluation and Management of Asymptomatic Carotid Artery Stenosis: Pharmacological Optimization, Nursing Care Coordination, and Radiological Diagnostic Integration

Nawal Ahmed Abdu Hamdi, Yousef Alharbi, Ali Alharbi, Ahmed Alshehri, Fawaz Alotaibi, Ziad Bin Badi Hamoud Al-Harbi, Sultan Aldosari, Sabah Abdulrahman Nasser Alshuhri, Nouf Abdulrahman Alnamlah, Sultan Mufareh Ahmed Qusadi, Mona Ahmed Kariri, ‏Mohammad Ayed H Alenizi, Majed Ahmed Abualsayl
article en

Abstract

Background: Asymptomatic carotid artery stenosis (ACAS), a narrowing of the carotid artery without recent neurological symptoms, is a common manifestation of systemic atherosclerosis and a marker for increased stroke and cardiovascular risk. Its management balances the prevention of future stroke against the risks of intervention. Aim: This review provides an interdisciplinary update on the evaluation and management of ACAS, integrating perspectives from radiological diagnostics, pharmacological optimization, and nursing care coordination to guide evidence-based, patient-centered decision-making. Methods: The synthesis is based on a comprehensive analysis of current guidelines, clinical trials, and cohort studies. It evaluates the roles of various diagnostic imaging modalities (duplex ultrasound, CTA, MRA) for risk stratification and examines the efficacy of best medical therapy (BMT) versus revascularization (CEA, CAS, TCAR). Results: Contemporary BMT, including statins, antiplatelets, and aggressive risk factor control, has significantly reduced the annual ipsilateral stroke risk to approximately 0.9-1%. This diminished baseline risk narrows the net benefit of routine revascularization. Current management therefore prioritizes BMT for most patients, reserving intervention for those with high-risk features such as stenosis progression, plaque vulnerability (e.g., intraplaque hemorrhage), or impaired cerebrovascular reserve. Conclusion: The management of ACAS has evolved towards a personalized, medical-first approach. Interdisciplinary collaboration is essential to identify high-risk patients who may benefit from revascularization while ensuring the majority receive optimized BMT. This strategy, supported by rigorous nursing coordination and advanced radiological diagnostics, optimizes outcomes by minimizing stroke risk and procedural harm.

Saudi Journal of Medicine and Public HealthVol. 2(2)
Ministry of Health (MY), King Abdullah University Hospital (JO), Ministry of Health (TO), Ministry of Interior (HU), Ministry of Health (IQ), Ministry of Health of the Russian Federation (RU), Ministry of Health (SI), Primary Health Care (QA), Ministry of Health (BW), Ministry of Health (MM), Ministry of Health (PE)
Openalex Percentile: Top 58%
Cerebrovascular and Carotid Artery Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.